Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women

被引:59
作者
Cook, JA
Grey, D
Burke-Miller, J
Cohen, MH
Anastos, K
Gandhi, M
Richardson, J
Wilson, T
Young, M
机构
[1] Univ Illinois, Dept Psychiat, Ctr Mental Hlth Serv Res & Policy, Chicago, IL 60603 USA
[2] Cook Cty Hosp, Chicago, IL 60612 USA
[3] Montefiore Med Ctr, Bronx, NY 10467 USA
[4] Univ So Calif, Los Angeles, CA 90089 USA
[5] SUNY Albany, Albany, NY 12246 USA
[6] Georgetown Univ, Med Ctr, Washington, DC 20057 USA
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2006年 / 18卷 / 02期
关键词
D O I
10.1080/09540120500159284
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study examines the effects of treated and untreated depressive symptoms on the likelihood of utilization of highly active antiretroviral therapy (HAART) among a multi-site cohort of HIV-infected women who screened positive for probable depression. Data were collected biannually from 1996 through 2002 in a prospective cohort study. Random-effects regression analysis was used to estimate the longitudinal effects of mental health treatment on the probability of HAART utilization, controlling for clinical indicators (CD4 count, viral load), demographic features (race/ ethnicity, income), and behavioural factors (recent crack, cocaine, or heroin use). Use of antidepressants plus mental health therapy, or use of mental health therapy alone significantly increased the probability of HAART utilization, compared to receiving no depression treatment. Use of antidepressants alone did not differ significantly from receiving no depression treatment. African American women and those who used crack, cocaine, or heroin also were less likely to use HAART. These findings suggest that efforts to enhance depressed women's access to psychopharmacologic treatment and therapy may increase their use of the most effective HIV therapies.
引用
收藏
页码:93 / 100
页数:8
相关论文
共 51 条
[1]   Culturally sensitive validation of screening questionnaires for depression in older African-Caribbean people living in south London [J].
Abas, MA ;
Phillips, C ;
Carter, J ;
Walter, J ;
Banerjee, S ;
Levy, R .
BRITISH JOURNAL OF PSYCHIATRY, 1998, 173 :249-254
[2]   Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival [J].
Anderson, KH ;
Mitchell, JM .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (20) :3114-3120
[3]   Underdiagnosis of depression in HIV - Who are we missing? [J].
Asch, SM ;
Kilbourne, AM ;
Gifford, AL ;
Burnam, MA ;
Turner, B ;
Shapiro, MF ;
Bozzette, SA .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 (06) :450-460
[4]   Issues in the psychiatric treatment of African Americans [J].
Baker, FM ;
Bell, CC .
PSYCHIATRIC SERVICES, 1999, 50 (03) :362-368
[5]   When should we delay highly active antiretroviral therapy? [J].
Bangsberg, DR ;
Moss, A .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1999, 14 (07) :446-448
[6]   The Women's Interagency HIV Study [J].
Barkan, SE ;
Melnick, SL ;
Preston-Martin, S ;
Weber, K ;
Kalish, LA ;
Miotti, P ;
Young, M ;
Greenblatt, R ;
Sacks, H ;
Feldman, J .
EPIDEMIOLOGY, 1998, 9 (02) :117-125
[7]   Protease inhibitor use among a community sample of people with HIV disease [J].
Bing, EG ;
Kilbourne, AM ;
Brooks, RA ;
Lazarus, EF ;
Senak, M .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 20 (05) :474-480
[8]  
Boland R, 1997, AM J PSYCHIAT, V154, P1632, DOI 10.1176/ajp.154.11.1632-a
[9]  
Chaudhry HR, 1998, HUM PSYCHOPHARM CLIN, V13, P419, DOI 10.1002/(SICI)1099-1077(199808)13:6<419::AID-HUP13>3.0.CO
[10]  
2-1